Market Tracker

01/30 6:05pm ET

Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

2.12
Data as of Jan 30
 -0.098 / -4.41%
Today’s Change
1.25
Today|||52-Week Range
5.93
+42.42%
Year-to-Date
No recent news for Alexza Pharmaceuticals Inc.

Today’s Trading

Previous close2.22
Today’s open2.22
Day’s range2.11 - 2.26
Volume28,513
Average volume (3 months)160,732
Market cap$41.2M
Dividend yield--
Data as of 3:59pm ET, 01/30/2015

Growth & Valuation

Earnings growth (last year)-6.25%
Earnings growth (this year)-1.26%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,075.41%
P/E ratioNM
Price/Sales1.65
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RGDORegado Biosciences I...+0.10+8.85%
IMNPImmune Pharmaceutica...-0.02-1.11%
ENZNEnzon Pharmaceutical...-0.03-3.44%
OGXIOncoGenex Pharmaceut...-0.01-0.50%
Data as of 4:00pm ET, 01/30/2015

Financials

Next reporting dateMarch 9, 2015
EPS forecast (this quarter)-$0.68
Annual revenue (last year)$47.8M
Annual profit (last year)-$39.6M
Net profit margin-82.81%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Thomas Braxton King
Chief Operations Officer &
Executive VP-Operations
Robert A. Lippe
Corporate headquarters
Mountain View, California

Forecasts